Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity

Rachaneekorn Jevprasesphant1, Jeffrey Penny, David Attwood

  • 1School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.

Pharmaceutical Research
|November 19, 2003
PubMed
Abstract

Insights

Surface modification of polyamidoamine (PAMAM) dendrimers with lauroyl chloride reduced cytotoxicity and enhanced permeation through Caco-2 cell monolayers. These modified dendrimers can traverse epithelial barriers via paracellular and transcellular routes.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Cell Biology

Background:

  • Dendrimers, a class of hyperbranched polymers, are explored for drug delivery and biomedical applications.
  • Understanding their interaction with biological barriers like the intestinal epithelium is crucial for in vivo efficacy.

Purpose of the Study:

  • To assess the cytotoxicity and permeation of polyamidoamine (PAMAM) dendrimers and their surface-modified variants.
  • To elucidate the transport mechanisms of these dendrimers across Caco-2 cell monolayers.

Main Methods:

  • Cytotoxicity evaluated using MTT assay.
  • Monolayer integrity assessed via transepithelial electrical resistance (TEER) and [14C]mannitol permeability.
  • Dendrimer apparent permeability (Papp) measured under various conditions (temperature, chemical modifiers).

Main Results:

  • Dendrimer cytotoxicity and permeation increased with concentration and generation.
  • Cationic dendrimers exhibited higher cytotoxicity and Papp than anionic ones.
  • Lauroyl chloride conjugation reduced cytotoxicity and enhanced permeation, with effects varying by the number of lauroyl chains.

Conclusions:

  • Surface engineering significantly alters PAMAM dendrimer properties.
  • Lauroyl-PAMAM dendrimer conjugates demonstrate reduced cytotoxicity and improved Caco-2 cell monolayer permeation.
  • Both unmodified and modified PAMAM dendrimers can cross epithelial monolayers via paracellular and transcellular pathways.